884 public posts
Want to take advantage of all our features? Just log in!
or
HCC (hepato cellular carcinoma ) patient survey
Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or cabozantinib)? If so, we’d like to ask for your help. We’d like your feedback on a survey we’re helping to create.
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Scrabbling around for an example, let us suppose haemochromatosis is present in one person but not the other. This could result in one having very high ferritin and suffering iron overload; the other being iron deficient.